Solid Tumours
Product Name |
Application |
Region |
ME001-Tumour suppressor mix 1 (basic research) |
Tumour suppressor genes |
Various |
ME002-Tumour suppressor mix 2 (basic research) |
Tumour suppressor genes |
Various |
ME011-MMR |
Mismatch repair genes (MMR) |
MLH1, MSH2, MSH6, MLH3, MSH3, PMS2, MGMT |
ME012-MGMT-IDH1-IDH2 |
Gliomas |
MGMT, IDH1, IDH2 |
ME024-9p21 |
Tumours, Cutaneous melanoma |
9p21, CDKN2A, CDKNA2B |
ME042-CIMP (basic research) |
CpG Island Methylator Phenotype |
Various |
P004-ERBB2 |
Cancer |
ERBB2 (HER2-NEU) 17q21.1 |
P014-Chromosome 8 |
Tumour research |
Chromosome 8 |
P027-Uveal melanoma |
Uveal melanoma |
1p, chr.3, 6p, 8q |
P047-RB1 |
Retinoblastoma (RB) |
RB1 13q14 |
P056-TP53 |
Li-Fraumeni syndrome (LFS) and tumour analysis |
TP53 17p13.1 |
P063-FHIT-WWOX |
Diverse tumour types, epileptic encephalopathy |
FHIT (3p14.2) and WWOX (16q23.1) |
P078-Breast tumour |
Breast tumour |
various |
P083-CDH1 |
Hereditary diffuse gastric cancer |
CDH1 at 16q22.1 |
P088-Oligodendroglioma 1p-19q |
Oligodendroglioma |
1p, 19q, IDH1/2, CDKN2A/2B |
P105-Glioma-2 |
Glioma, malignant |
EGFR, TP53, PTEN + various other |
P146-CRC GAIN (basic research) |
Colon cancer |
Various |
P157-20q region |
Colon cancer, breast cancer and various others |
20q (BCL2L1, MYBL2, ZNF217, DNMT3B, AURKA, GNAS) |
P175-Tumour Gain (basic research) |
Tumour Gain |
various |
P181-Centromere mix 1 |
Centromeric screening |
Centromeres |
P182-Centromere mix 2 |
Centromeric testing |
Centromeres |
P215-EXT |
Multiple Osteochondromas |
EXT1 8q24, EXT2 11p11 |
P225-PTEN |
Cowden syndrome and tumour analysis |
PTEN 10q23 |
P251-NB mix 1 |
Neuroblastoma |
1p36, 3p22/3p21.3 and 11q23 |
P252-NB mix 2 |
Neuroblastoma |
2p24.1/MYCN, 2q33, 17p13/TP53, 17q |
P253-NB mix 3 |
Neuroblastoma |
Chromosomes 4, 7, 9, 12, 14 |
P258-SMARCB1 |
Rhabdoid tumors |
SMARCB1 22q11.2 |
P294-Tumour Loss (basic research) |
Tumour Loss |
various |
P298-BRAF-HRAS-KRAS-NRAS (basic research) |
Various tumour types |
BRAF, HRAS, KRAS, NRAS |
P301-Medulloblastoma mix 1 |
Medulloblastoma |
Chr. 6, Chr. 14, Chr. 16, Chr. 17. |
P302-Medulloblastoma mix 2 |
Medulloblastoma |
Chr. 2, Chr. 3, Chr. 7, Chr. 9 |
P303-Medulloblastoma mix 3 |
Medulloblastoma |
Chr. 1, Chr. 4, Chr. 5, Chr. 8, Chr. 10, Chr. 20 |
P308-MET |
Papillary renal carcinoma, various cancers |
MET 7q31, PTEN 10q23.31, LRRK2 12q12 |
P315-EGFR |
Tumours, solid |
EGFR 7p11 |
P323-CDK4-HMGA2-MDM2 |
Sarcoma and other tumour types |
chromosome 12, MDM2, CDK4 and HMGA2 genes |
P370-BRAF-IDH1-IDH2 (basic research) |
Gliomas |
BRAF, IDH1, IDH2, FGFR1, MYB, MYBL1, CDKN2A |
P376-BRCA1ness |
BRCA1-like breast cancer profile |
various |
P378-MUTYH |
Colon cancer, stomach cancer (hereditary) |
1p34 and 15q13 |
P380-Wilms' tumour |
Wilms' tumour |
various |
P413-CRC LOSS (basic research) |
Colorectal adenoma/carcinoma |
8p, 15q, 17p, 18q |
P417-BAP1 |
Melanocytic tumours, mesothelioma |
BAP1, 3p21.1 |
P419-CDKN2A/2B-CDK4 |
Familial melanoma |
CDKN2A, CDKN2B, CDK4, MITF E318K |
P429-SDHA-MAX |
Paraganglioma and pheochromocytoma |
5p15.3 and 14q23.3 |
P433-ARID1A-ARID1B |
Neuroblastoma, ovarian cancer + various other tumour types + mental retardation |
ARID1A, ARID1B |
P448-PARD3 |
PARD3 |
10p11.21-p11.22 |
P455-LZTR1 |
Schwannomatosis |
22q11.21 |
P458-Gastric cancer |
Gastric cancer |
various |
P466-CDC73 |
HPT jaw tumour syndrome, famial hyperparathyroidism, parathyroid carcinoma |
CDC73 |
P472-SUFU |
Familial Medulloblastoma and Meningioma |
10q24.32 |